RO96749B1 - Vasoactive medicament - Google Patents
Vasoactive medicamentInfo
- Publication number
- RO96749B1 RO96749B1 RO126978A RO12697887A RO96749B1 RO 96749 B1 RO96749 B1 RO 96749B1 RO 126978 A RO126978 A RO 126978A RO 12697887 A RO12697887 A RO 12697887A RO 96749 B1 RO96749 B1 RO 96749B1
- Authority
- RO
- Romania
- Prior art keywords
- drug
- effects
- rutacil
- tablets
- well
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inventia de fata valorifica drep principiu activ un derivat flavonoidic diacetilat (Rutacil), cu proprietati capilaroprotectoare superioare, precum si cu efecte hipocolesterolemiante, hipolipemiante, antiagregant-plachetare, antiinflamatoare si diuretice. Asocierea acidului ascorbic, a vitaminei PP sub forma de xantinol-nicotinat, a ATP si a ionilor de Mg2+, ca glutamat, potenteaza efectele Rutacilului în contextul medicamentului. Medicamentul este indicat în tratamentul tulburarilor circulatorii, atât centrale, cât si periferice, al tulburarilor circulatorii cauzate de traumatisme cranio-cerebrale sau pe fond de scleroza si diabet, precum si ca stabilizator al tensiunii. Prezentarea medicamentului sub forma de comprimate usureaza administrarea si dozarea acestuia. Fiind lipsit de toxicitate si având efecte secundare nesemnificative, medicamentul poate fi aplicat pe perioadele lungi de timp si în doze ce pot varia dupa caz, de la 3x1 pâna la 3x4 comprimate pe zi.The present invention advantageously employs a diacetylated flavonoid derivative (Rutacil) with higher capillary-protective properties, as well as with hypocolesterolemitic, hypolipidemic, antiaggregant-platelet, anti-inflammatory and diuretic effects. The combination of ascorbic acid, vitamin PP in the form of xanthinol-nicotinate, ATP and Mg2 + ions, such as glutamate, potentiates the effects of Rutacil in the context of the drug. The drug is indicated for the treatment of circulatory disorders, both central and peripheral, of circulatory disorders caused by cranio-cerebral trauma or on the basis of sclerosis and diabetes, as well as as a stabilizer of tension. Presentation of the drug in the form of tablets facilitates its administration and dosing. Being unlikely and having minor side effects, the drug can be applied over long periods of time and in doses that may vary from 3x1 to 3x4 tablets a day.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO126978A RO96749B1 (en) | 1987-02-11 | 1987-02-11 | Vasoactive medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO126978A RO96749B1 (en) | 1987-02-11 | 1987-02-11 | Vasoactive medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
RO96749A2 RO96749A2 (en) | 1989-04-28 |
RO96749B1 true RO96749B1 (en) | 1989-04-29 |
Family
ID=20120412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RO126978A RO96749B1 (en) | 1987-02-11 | 1987-02-11 | Vasoactive medicament |
Country Status (1)
Country | Link |
---|---|
RO (1) | RO96749B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19538666A1 (en) * | 1995-10-17 | 1997-04-24 | Leniger Follert Elfriede Prof | Medicines used to treat arterial occlusive diseases, microangiopathies and microcirculation disorders |
-
1987
- 1987-02-11 RO RO126978A patent/RO96749B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RO96749A2 (en) | 1989-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO922940L (en) | FIVE-JOINT HETEROCYCLIC COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | |
NO944778L (en) | Des-Tyr-dynorfinanaloger | |
DE324227T1 (en) | COMPOSITION FOR INCREASING INTRA-CELL-ATP LEVELS AND PHYSICAL PERFORMANCE LEVELS AND FOR INCREASING THE SPEED OF Wounds Healing. | |
CA2114014A1 (en) | Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine | |
DE68910159T2 (en) | Dosage form for administration in human medicine. | |
IT1170215B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF STATES OF ACUTE RENAL INSUFFICIENCY | |
ATE240344T1 (en) | NOR-PREGNANES TO INDUCE HYPOTHALAMIC EFFECTS | |
DE68909409T2 (en) | MEDICAL DOSAGE FOR ADMINISTRATION TO FISH. | |
MY103741A (en) | Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process | |
KR970025615A (en) | Cancer metastasis inhibitor | |
ITRM910002A1 (en) | USE OF ACETYL L-CARNITINE IN THERAPEUTIC TREATMENT OF COMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT. | |
DE68926115D1 (en) | METHOD FOR TREATING ACNE | |
RO96749B1 (en) | Vasoactive medicament | |
ES8705763A1 (en) | Pharmaceutical compositions containing gels. | |
DE69015910D1 (en) | Pharmaceutical use of fatty acids. | |
MY130107A (en) | Piperidylmethyl-substituted chroman derivatives | |
DK1231908T3 (en) | A pharmaceutical composition comprising an NO donor compound and its use | |
KR880009656A (en) | Treatment or prophylaxis of local periodontal disease | |
GB1460325A (en) | Pharmaceutical composition intended for relieving pain and producing analgesia | |
KR940006600A (en) | Use of direct inhibitors of thrombin for the manufacture of medicinal products with thrombolytic activity | |
DE68901656D1 (en) | PHARMACEUTICAL COMPOSITION FOR REDUCING THE SIDE EFFECTS OF MEDICINAL PRODUCTS CONTAINING PLATINUM. | |
KR880010762A (en) | Composition and Method for Treatment of peptic Ulcers | |
ATE55254T1 (en) | REDUCING THE TOXIC EFFECTS OF ANTHRACHINONE MEDICATIONS. | |
SU950391A1 (en) | Multiple sclerosis treatment method | |
ES458413A1 (en) | Pharmaceutical composition |